Bioavailability and feasibility of subcutaneous 5-fluorouracil.
暂无分享,去创建一个
J. Kneer | K. Brunner | T. Cerny | C. Crevoisier | M. Borner
[1] S. Taylor. Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.
[2] H. Bruckner,et al. Chemotherapy of advanced cancer of the colon and rectum. , 1991, Seminars in oncology.
[3] K. Brunner,et al. Bioavailability of subcutaneous ifosfamide and feasibility of continuous outpatient application in cancer patients. , 1990, Annals of Oncology.
[4] R. Klein,et al. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. , 1990, Annals of internal medicine.
[5] J G Fryer,et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Macdonald. Continuous low-dose infusion of fluorouracil: is the benefit worth the cost? , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] R. Pazdur,et al. Low‐dose continuous infusion 5‐fluorouracil. Evaluation in advanced breast carcinoma , 1989, Cancer.
[8] W. Panje,et al. A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer , 1989, Cancer.
[9] M. al-Sarraf. Head and neck cancer: chemotherapy concepts. , 1988, Seminars in oncology.
[10] J. Jacobs,et al. A randomized trial of cisplatin (CACP) + 5‐fluorouracil (5‐FU) infusion and CACP + 5‐FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck , 1985, Cancer.
[11] W. Ensminger,et al. Sensitive high-performance liquid chromatographic method for the determination of 5-fluorouracil in plasma. , 1985, Journal of chromatography.
[12] J. Jacobs,et al. Cisplatin and 5‐fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck , 1984, Cancer.
[13] R. Dedrick,et al. Nonlinear pharmacokinetic models for 5‐fluorouracil in man: Intravenous and intraperitoneal routes , 1980, Clinical pharmacology and therapeutics.
[14] V. Vaitkevicius,et al. Comparison of continuously infused 5‐fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma , 1975, Cancer.